Hereditary Cancer Panel

Published in Data Releases
September 03, 2025
1 min read
Hereditary Cancer Panel

The Oxford Nanopore Technologies’ Hereditary Cancer Panel is a robust and comprehensive sequencing assay that targets 258 genes associated with hereditary cancer risk. It uses adaptive sampling, a rapid and flexible on-instrument target enrichment method that eliminates the need for baits, primers, or lengthy library preparation.

This data release includes nine Genome in a Bottle NA24385 (HG002) sequencing datasets, in a 3-plex format across three PromethION Flow Cells. The panel leverages Oxford Nanopore’s flexible read‑length capability to generate kilobase‑scale reads appropriate for this assay. This capability enables accurate detection of complex structural variants, single nucleotide variants, and insertions or deletions. It also supports haplotype phasing and can resolve challenging regions.

In addition to variant detection, the use of direct DNA sequencing allows for methylation analysis, providing an integrated genomic and epigenomic view of each sample. This enables researchers to explore features such as gene promoter silencing and parent-of-origin effects.

The following cell line sample was obtained from the NIGMS Human Genetic Cell Repository at the Coriell Institute for Medical Research: GM24385

Sample

DetailDescription
Sample NameHG002
OrganismHuman
Molecule TypegDNA
Sample TypeCultured cell line
Biological replicates3
Flow Cell replicates3
Hereditary Cancer PanelHCP18 (18 samples) | HCP72 (72 samples)

Preparation

Sample preparation was performed according to protocols contained within the Hereditary Cancer Panel Bundle.

DetailDescription
ExtractionHereditary Cancer Panel
Library PrepHereditary Cancer Panel
KitNative Barcode ligation Kit V14 (SQK-NBD114-24)

Further preparation information such as sample storage suggestions can be found on the Oxford Nanopore Website.

Sequencing

Sequence data was generated using the following configuration:

DetailDescription
Flow CellFLO-PRO114M
DevicePromethION
ChemistryR10.4.1
Basecall ModelHAC v4.3.0
Modified Base Models5mC & 5hmC CG contexts
MinKNOW VersionMinKnow 6.4 (25.03.7 focal)

Data Download

The dataset is available for anonymous download, without login, from a public Amazon Web Services S3 bucket. The bucket is part of the Open Data on AWS project enabling sharing and analysis of a wide range of data. The data can be downloaded with the AWS CLI command:

aws s3 sync --no-sign-request s3://ont-open-data/hereditary_cancer_2025.09 hereditary_cancer_2025.09

See the tutorials page for information on downloading the dataset. You can also browse and download the files in your web browser courtesy of 42basepairs.

Folder nameSizeDescription
raw2.7 TBMinKNOW output files
basecalling_selected_barcodes334 GBBAM files
analysis249 GBWorkflow outputs

Analysis

Data was analysed using the wf-hereditary-cancer(v1.2.1) workflow, an EPI2ME pipeline available as part of the Hereditary Cancer Panel Bundle.

The analysis results are located in the S3 bucket under the prefix:

s3://ont-open-data/hereditary_cancer_2025.09/analysis
  • Further information about the Hereditary Cancer Panel
  • Store purchase
  • Hereditary Cancer Panel Protocol

Tags

#datasets

Share

Table Of Contents

1
Sample
2
Preparation
3
Sequencing
4
Data Download
5
Analysis
6
Related Materials

Related Posts

Metagenomic sequencing for pathogen surveillance
September 05, 2025
1 min

Quick Links

WorkflowsOpen DataContact

Social Media

© 2020 - 2025 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.